Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis (Q39395362)
Jump to navigation
Jump to search
scientific article published on April 16, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis |
scientific article published on April 16, 2003 |
Statements
1 reference
Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis (English)
1 reference
1 reference
J. D. Ringe
A. Dorst
H. Faber
K. Ibach
16 April 2003
1 reference
1 reference
Identifiers
1 reference